| Gene symbol | TNFRSF8 | Synonyms | CD30, D1S166E, Ki-1 | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1p36.22 | dbXrefs | |
| Description | TNF receptor superfamily member 8 | ||||
| GTO ID | GTC3014 |
| Trial ID | NCT05352828 |
| Disease | Hodgkin's Lymphoma |
| Altered gene | CD30 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD30 CAR-T cells |
| Co-treatment | Nivolumab |
| Phase | Phase1 |
| Recruitment status | Active, Not Recruiting |
| Title | Autologous CD30.CAR-T in Combination With Nivolumab in cHL Patients After Failure of Frontline Therapy |
| Year | 2022 |
| Country | United States |
| Company sponsor | Tessa Therapeutics |
| Other ID(s) | TESSCAR003 |
| Cohort 1 | |||||||||||||
|
|||||||||||||